[Osteoarthritis and analgesic-antiphlogistic therapy. Preliminary report on the tolerability and efficacy of nabumetone treatment].

Twenty patients (1 male, 19 females, mean age 62, range 45-86 years) with acute stage articular disorders (gonarthritis, coxarthritis, humero-scapular periarthritis) were treated for 10 days with 1 g nabumetone daily. Marked pain was present in all cases. Therapeutic activity was assessed on the basis of changes of objective clinical signs and symptoms… CONTINUE READING